2008-2021: U.S. new drug listing prices rose nearly 90 times
- Aspirin: Study Finds Greater Benefits for These Colorectal Cancer Patients
- Cancer Can Occur Without Genetic Mutations?
- Statins Lower Blood Lipids: How Long is a Course?
- Warning: Smartwatch Blood Sugar Measurement Deemed Dangerous
- Mifepristone: A Safe and Effective Abortion Option Amidst Controversy
- Asbestos Detected in Buildings Damaged in Ukraine: Analyzed by Japanese Company
2008-2021: U.S. new drug listing prices rose nearly 90 times
- Red Yeast Rice Scare Grips Japan: Over 114 Hospitalized and 5 Deaths
- Long COVID Brain Fog: Blood-Brain Barrier Damage and Persistent Inflammation
- FDA has mandated a top-level black box warning for all marketed CAR-T therapies
- Can people with high blood pressure eat peanuts?
- What is the difference between dopamine and dobutamine?
- How long can the patient live after heart stent surgery?
2008-2021: U.S. new drug listing prices rose nearly 90 times
On June 7, Harvard Medical School professors Aaron S. Kesselheim, Benjamin N. Rome and assistant researcher Alexander C. Egilman published “Trends in Prescription Drug Launch Prices, 2008-2021” article.
A total of 548 (95%) of the 576 drugs that were first marketed between 2008 and 2021 were included in the study, 3 diagnostic drugs and 25 drugs for which annual prices could not be estimated were excluded.
Of these, 357 (65%) were new molecular entities, 139 (25%) were biologics, 182 (33%) were rare disease drugs, 64 (12%) were marketed through the accelerated approval pathway, 119 (22%) were %) is a tumor drug.
The most expensive drugs are rare disease drugs and oncology drugs, with a median price of $168,441/year and $155,091/year, respectively.
Statistics found that from 2008 to 2021, the annual growth rate of new drug listing prices was 20.4%, adjusted according to drug characteristics, 13%, and the annual growth rate of net prices was 10.7%.
The median price has increased from $2,115/yuan in 2008 to $180,007/year in 2021. The proportion of drugs priced above $150,000/year was 9% (18/197) in 2008-2013 and 47% (42/89) in 2020-2021.
The median net price has increased from $1,376/year in 2008 to $159,042/year in 2021.
The article said that new drug price growth trends outpaced other medical services, and that manufacturers routinely raise prices over time after a drug is on the market.
In response to current trends, the U.S. could stop allowing drug makers to set prices freely and follow other industrialized nations in negotiating drug prices when they come to market.
2008-2021: U.S. new drug listing prices rose nearly 90 times
(source:internet, reference only)
Disclaimer of medicaltrend.org
Important Note: The information provided is for informational purposes only and should not be considered as medical advice.
